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Technical Notes
Determination of Cabergoline by Electrospray
Ionization Tandem Mass Spectrometry: Picogram
Detection via Column Focusing Sample
Introduction
Bruce A. Kimball,* Thomas J. DeLiberto,² and John J. Johnston
USDA/APHIS/NWRC, 4101 LaPorte Avenue, Fort Collins, Colorado 80521
An electrospray ionization tandem mass spectrometric
method was developed for low-picogram detection of an
ergot alkaloid, cabergoline, in coyote plasma extracts.
Cabergoline is under investigation as an abortifacient in
canid species. Central to the successful development of
this method was the ability to introduce relatively large
sample volumes into the mass spectrometer. This was
achieved by focusing the analyte on a conventional high-
performance liquid chromatography guard column prior
to elution into the spectrometer. Volumes up to at least
900 íL could be injected onto the guard column using a
100% aqueous mobile phase. Cabergoline retained on the
column was eluted as a discreet band into the mass
spectrometer by the rapid addition of methanol (30%) to
the mobile phase. As compared to flow injection sample
introduction, the ability to inject larger sample volumes
led to a greatly lowered detection limit. Using this tech-
nique and a modification of a previously reported extrac-
tion procedure, cabergoline could be determined in coyote
plasma at concentrations as low as 9 pg of cabergoline/
mL of plasma.
Cabergoline, a prolactin-inhibiting ergot derivative, is used for
the treatment of hyperprolactinemia and Parkinson's disease in
humans.1 Because of prolactin's unique role in maintaining
pregnancy in felines, canines, and rodents, cabergoline is also
being investigated as a reproductive control drug in such
species.2-7 Scientists at the National Wildlife Research Center, a
U.S. Department of Agriculture research facility, are investigating
cabergoline as a contraceptive tool to reduce coyote (Canis
latrans) predation on livestock and game species. Contraception
is considered a viable component of integrated predation manage-
ment because coyotes without pups are less likely to kill larger
prey species such as lambs, calves, and fawns.8,9
To examine uptake and retention of cabergoline administered
to coyotes, a method for its determination in plasma was required.
Studies have indicated that doses as small as 5 íg/kg were
effective in terminating pregnancies in dogs and cats.6,10 Thus,
we anticipated that a method capable of detecting cabergoline in
plasma at concentrations in the low parts-per-trillion would be
required.
Methods for the determination of cabergoline in human plasma
have previously been reported.1,11 The more recent method
employed high-performance liquid chromatography (HPLC)/
tandem mass spectrometry (MS-MS) using a triple quadrapole
analyzer to greatly improve sensitivity versus the former. Many
studies have demonstrated the applicability of tandem mass
spectrometry paired with flow injection,12 reversed-phase HPLC,13-15
and fast gradient HPLC.16 Nonchromatographic introduction of
the sample is often applicable to clinical analyses because of the
increased selectivity of tandem techniques. Furthermore, flow
injection decreases instrumental run time and increases sample
throughput. Accordingly, we investigated a method employing flow
injection sample introduction for the determination of cabergoline
in plasma extracts by MS-MS.
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We modified the extraction method of Allievi and Dostert1 for
the determination of cabergoline in coyote plasma. After evaluating
flow injection sample introduction of plasma extracts, we devel-
oped a technique for focusing cabergoline on a guard column and
eluting it into an ion trap mass spectrometer for MS-MS analysis.
This column focusing technique allowed for injection volumes of
at least 900 íL, which in turn resulted in a detection limit for
cabergoline in coyote plasma that rivals that reported for human
plasma using a triple quadrapole instrument.1
EXPERIMENTAL SECTION
Solutions. Methanol (HPLC grade, EM Scientific, Gibbstown,
NJ) and acetic acid (Fisher Scientific, Fair Lawn, NJ) were used
to prepare the mobile phases. The aqueous portion of the mobile
phase consisted of 1% acetic acid in water, while the organic
portion was 100% methanol. Concentrated cabergoline (Pharmacia
& Upjohn Inc., Peapack, NJ) standards were prepared in methanol.
Intermediate and working standards were prepared from the
concentrated standard with 1% acetic acid in water. Ethyl acetate
(HPLC grade, Fisher Scientific), methylene chloride (HPLC grade,
Fisher Scientific), and a borate buffer solution (pH 10, Fisher
Scientific) were used in the extraction of plasma samples.
Instrument. Mobile phase was delivered with a HP1100 binary
pump, from which the mixing column was removed (Agilent
Technologies, Palo Alto, CA). A HP1100 autosampler (Agilent
Technologies) equipped with a 1.0-mL injection loop was used to
inject sample and standard solutions into the mass spectrometer.
A guard column (4-mm i.d., Aquasil, Keystone Scientific, Belle-
fonte, PA) was placed between the autosampler and mass
spectrometer. Solutions were analyzed with an ion trap mass
spectrometer equipped with an electrospray ionization source
(LCQ, ThermoQuest, San Jose, CA).
Extraction Procedure. Coyote plasma samples (2.0 mL) were
placed in 25-mL culture tubes, and 2.0 mL of buffer solution (pH
10) was added. Ethyl acetate (8.0 mL) was added to the mixture,
and the solutions were thoroughly mixed. Following centrifuga-
tion, the ethyl acetate was removed and the extraction repeated.
The combined ethyl acetate extracts were dried under nitrogen
at 60 °C in 25-mL culture tubes. Methylene chloride (350 íL) was
added to tubes containing the dried extracts and mixed vigorously.
The methylene chloride extracts were transferred to individual
2-mL microcentrifuge tubes, and 1.00 mL of 1% acetic acid was
added to each tube. The microcentrifuge tubes were shaken
thoroughly with a vortex mixer and centrifuged. The aqueous
portion (top layer) was transferred to individual autosampler vials
for injection into the instrument.
Column Focusing Sample Introduction. Sample extracts
and standard solutions (5.0-900 íL) were injected into the
aqueous mobile phase (1% acetic acid in water) delivered at a flow
rate of 1.0 mL/min. These mobile-phase conditions were main-
tained for 3 min during which time the sample loop was swept
with three loop volumes and the analyte was sorbed onto the
packing material of the guard column (Table 1). The autosampler
bypass valve was then actuated so that mobile-phase flow bypassed
the sample loop. At the same time, a fast gradient program was
employed to increase the organic (methanol) composition of the
mobile phase from 0 to 30% over the course of 0.01 min. The new
mobile-phase conditions were maintained for 0.5 min to perform
the elution of the analyte. Cabergoline was eluted from the guard
column at 3.8 min of the ªchromatographicº run. The methanol
composition of the mobile phase was rapidly increased from 30
to 90% at 3.5 min (Table 1). At a run time of 4.0 min, the
autosampler bypass valve was switched back to the main pass
position, allowing the mobile phase to sweep the sample loop. At
4.5 min, the mobile-phase methanol composition was rapidly
decreased to zero percent. The entire run was 7.0 min in duration.
Analyte Detection. The mass spectrometer was operated in
the positive ion mode. The electrospray voltage was 3.5 kV, the
orifice (heated capillary) temperature was 245 °C, and the capillary
voltage was 8.0 V. Nitrogen sheath and auxiliary flows were 85
and 10% of maximum, respectively. The automated gain control
parameters included 1 microscan and 750 ms maximum injection
time. Tandem (MS-MS) experiments were conducted on the
parent mass of 452 m/z (3.0 m/z isolation width) with a relative
collision energy of 25%. The products of the tandem experiment
were scanned from 125 to 385 m/z. The chromatographic response
resulted from an extracted ion trace of the 381 m/z product.
Flow Injection Sample Introduction. Cabergoline solutions
were also analyzed using flow injection sample introduction.
Solutions were repeatedly injected into the aqueous mobile phase
flowing at 1.0 mL/min. No guard column was present between
the autosampler and mass spectrometer, and the mobile-phase
composition did not include a gradient. The mass spectrometer
and data acquisition parameters were identical to those employed
for column focusing sample introduction.
Sample Introduction Comparison. A 2.20 ng/mL caber-
goline solution was introduced into the mass spectrometer using
both column focusing (previously described) and flow injection
sample introduction (described above). Injection volumes of 25,
100, and 400 íL were employed and the resulting peak responses
compared visually.
Mobile-Phase Strength. To study the effect of changing
mobile-phase strength on column focusing sample introduction,
50 íL of a 2.20 ng/mL cabergoline solution was repeatedly injected
into the instrument (n ) 5). Three different elution conditions
were evaluated: 50, 35, and 30% methanol in the mobile phase at
the time of cabergoline elution. No other parameters were
changed (Table 1). Data obtained from elution with 30% methanol
were used to assess instrument repeatability.
Response Linearity. Detector response for column focusing
sample introduction was assessed using both constant and variable
sample volumes. In the constant-volume approach, 900 íL of five
cabergoline solutions ranging in concentration from 12.8 to 2120
pg/mL were injected into the instrument in triplicate (Table 2).
Conversely, a single cabergoline solution (2120 pg/mL) was
Table 1. Mobile-Phase Parameters Used for Sample
Introduction of Cabergoline Solutions
run time, min % MeOH comments
0.00 0 sample injection
3.00 0 sample loop bypass
3.01 30 begin analyte elution
3.50 30
3.51 90 begin column wash
4.00 90 sample loop mainpass
4.50 90
4.51 0 begin equilibration for next injection
7.00 0 end run
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repeatedly injected into the instrument to assess response linearity
when variable-injection volumes were employed. The solution was
injected in triplicate at each of five different volumes ranging from
5.0 to 900 íL (Table 2). Analysis of variance (ANOVA) was used
to assess the effect of injection method (constant versus variable
volume) on peak height response. Injection method was a fixed
effect and mass injected was included in the model as a covariate.
A one-factor ANOVA was also conducted with data obtained from
variable-volume injection to assess the impact of injection volume
on peak height response factors.
Bias and Repeatability. Seven replicate coyote plasma
samples (2.0 mL) were fortified with 100.0 íL of a 2210 pg/mL
cabergoline solution and subjected to the extraction procedures
previously described. The resultant samples had concentrations
of 110 pg/mL. Additionally, three control plasma samples (no
cabergoline) were similarly extracted. Extracts (400 íL) were
analyzed by column focusing sample introduction tandem mass
spectrometry.
Method Limits of Detection and Quantitation. Five replicate
coyote plasma samples (2.0 mL) were fortified at a concentration
of 15.9 pg/mL using a 2120 pg/mL cabergoline solution in 1%
acetic acid. The samples were extracted, and 400 íL of the extract
was injected into the instrument. Method limit of detection
(MLOD) was determined from the chromatographic response of
cabergoline, and the peak-to-peak chromatographic noise mea-
sured from each chromatogram. The MLOD was defined as the
cabergoline concentration that would be required to produce
cabergoline response equal to 2 times the chromatographic noise.
The method limit of quantitation (MLOQ) was calculated from
the responses obtained from analysis of seven replicate caber-
goline-fortified plasma samples used to assess method repeat-
ability. The MLOQ was defined as the cabergoline concentration
required to produce a response equal to 10 times the chromato-
graphic noise. The MLOD and MLOQ were determined for each
replicate and the mean values were calculated.
RESULTS AND DISCUSSION
The chromatograms produced by column focusing and flow
injection sample introduction demonstrate the utility of column
focusing as sample introduction technique (Figure 1). Superior
peak shape, improved signal-to-noise ratio, and sample volume
flexibility were observed with the column focusing technique. The
relationship between mobile-phase flow rate and injection volume
is critical in flow injection applications where chromatographic-
like peaks are desired. This is why very small injection volumes
(1-10 íL) are typically employed.12 We found flow injection
sample introduction ill-suited for our application because the
desired level of detection was not possible. Improved detection
could not be attained by increasing the injection volume (Figure
1). By comparison, the HPLC method of Allievi and Dostert1
yielded very low parts-per-trillion detection from 150-íL injections.
Flow injection sample introduction on an ion trap instrument
could not be expected to attain similar sensitivity because of two
limiting factors: injection volume and mass analyzer. First, 150
íL is 10 times greater than the typical injection volume employed
in flow injection.12 Both the inherent length of the sample plug
and the effects of longitudinal diffusion conspire to produce poor
chromatographic peak shape. Second, triple quadrapole instru-
ments yield better sensitivity versus ion trap analyzers through
use of selected reaction monitoring (SRM).17 Conversely, SRM
provides little added sensitivity over full-scan experiments with
the ion trap because all ions are ejected from the trap according
to m/z during its normal duty cycle. Instrument software takes
advantage of the ion trap duty cycle by scanning all reaction
products while allowing chromatographic traces to be produced
from extracted ions. Loss in sensitivity is countered by the added
qualitative data obtained during the scan event.
(17) Henry, C. Anal. Chem. 1998, 70, 533A-536A.
Table 2. Masses of Cabergoline Injected into the
Instrument for Assessment of Response Linearity
solution concn,
pg/mL
vol injected,
íL
cabergoline concn,
pg
2120 900 1910
1180 900 1060
108.0 900 97.2
61.5 900 55.4
12.8 900 11.5
2120 900 1910
2120 500 1060
2120 50.0 106.0
2120 25.0 53.0
2120 5.0 10.6
Figure 1. Flow injection sample introduction versus column focus-
ing. Variable-volume injection of a 2.2 ng/mL cabergoline solution
using identical mass spectrometric conditions, flow rate, and chro-
matographic scale. For flow injection introduction, a 100% aqueous
mobile phase (1% acetic acid in water) was employed at a flow rate
of 1.0 mL/min. Cabergoline was focused on the guard column with
the identical 100% aqueous mobile phase and eluted with a 30:70
methanol/ water mobile phase during column focusing experiment.
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The perception that tandem experiments often preclude
chromatographic separation may be inaccurate.18 Ion suppression
and matrix effects may substantially impact analyte specificity and
sensitivity, particularly with biological matrixes. However, our
combination of sample extraction and column focusing reduced
the likelihood of interference from ions or weakly basic matrix
components. Our extraction procedure was a modification of
Allievi and Dostert1 that partitioned the free base into an organic
solvent to prevent negative ions from accompanying the analyte
in the final extract. Formation of the sodiated analogue of
protonated cabergoline was similarly minimized.
The column focusing technique may also reduce electrospray
interferences from other matrix components. While not as efficient
as a HPLC separation, the digital elution process employed in this
technique can discriminate among components varying in affinity
to the stationary phase (capacity factor, k′). In other words,
cabergoline is eluted from the guard column in a manner similar
to solid-phase extraction (SPE).19 Also similar to SPE, the analyte
is eluted from the column in a discreet volume that can be
substantially smaller than the injection volume. The benefit of this
ªconcentrationº process can be best observed when comparing
flow injection and column focusing sample introduction (Figure
1).
Peak width, or more importantly, the number of data points
defining the cabergoline peak, was another important aspect of
this analysis that we attempted to optimize. Though the scanning
rate of the mass analyzer was maximized, the number of data
points defining the peak could be optimized chromatographically.
The mobile-phase strength could be adjusted such that the
cabergoline peak was defined by at least 10 data points. Peaks
produced by elution with 50% methanol were quite narrow and
consisted of only seven or eight data points (Figure 2). Elution
with 35 and 30% methanol yielded wider peaks with more data
points (8-9 and 10-11 points, respectively). Injection reproduc-
ibility was related to the number of data points that described
the peak. The relative standard deviation (RSD) of peak height
responses was lower when the 30% methanol mobile phase was
employed (6.1%) versus the 35 and 50% elution conditions (16.2
and 13.0%, respectively). Some peak width variability was also
observed among manufacturing lots of guard columns. Manipula-
tion of the methanol composition allowed for optimization of peak
width response when guard columns were changed.
Comparison of constant and variable injection demonstrated
that cabergoline response was a function of the mass of caber-
goline injected (F1,25 ) 3744; p < 0.001), but independent of
injection method (F1,25 ) 0.25; p ) 0.62). With peak height as the
response and cabergoline mass (pg) the independent variable,
similar detector response curves were obtained from both
constant- and variable-volume injections (Figure 3). Injection
volume did not impact cabergoline response factor (F4,9 ) 1.83; p
) 0.21), indicating that volumes ranging from 5.0 to 900.0 íL could
be injected onto the guard column without loss of performance.
This feature was useful for quantitative purposes, allowing calibra-
tion curves to be produced from injecting widely varying volumes
of a single calibration standard.
When plasma extracts were analyzed, it was typically not
possible to recover the entire 1.00 mL of the aqueous solution
from the final extraction step. Additionally, autosampler vials have
a ªvoid volumeº (solution at the bottom of the vial inaccessible to
the autosampler needle) limiting the sample volume available for
automated analysis. Taken together, these factors limited maxi-
mum injection volume of extracts to 400 íL.
Owing to the digital elution process and selectivity of tandem
mass spectrometry, extracts from the three control samples did
not produce interfering peaks corresponding to cabergoline.
Replicate analyses of seven plasma samples fortified at a caber-
goline concentration of 110 pg/mL yielded a mean recovery of
52.4% with a RSD of 25.4%. The MLOD was determined to be 8.7
(18) Matuszewski, B. K.; Constanzer, M. L.; Chavez-Eng, C. M. Anal. Chem.
1998, 70, 882-889.
(19) Johnston, J. J.; Primus, T. P.; Goldade, D. A. Recent Res. Dev. Agric. Food
Chem. 1997, 1, 211-220.
Figure 2. Cabergoline responses resulting from elution with 50, 35,
and 30% methanol in the mobile phase (50-íL injections of a 2.2
ng/mL cabergoline solution; flow rate 1.0 mL/min).
Figure 3. Cabergoline peak height response from two methods of
sample introduction. Constant-volume injections were made by
injecting 900 íL of cabergoline solutions of varying concentrations
(Table 2). Variable-volume injections were made by injecting varying
volumes of a 2120 pg/mL cabergoline solution (Table 2).
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pg cabergoline/mL plasma and the MLOQ was 59.7 pg/mL.
Considering the low fortification level tested, we were pleased with
52% analyte recovery from cabergoline-fortified coyote plasma
samples. Our recovery compares favorably with the 65% extraction
efficiency reported by Allievi and Dostert1 from similarly fortified
human plasma samples. However, they were able to report much
better overall accuracy (near 100%) and repeatability (10%) by
employing a 14C-labeled surrogate standard. Our poorer than
expected repeatability (RSD ) 25.4%) was greatly influenced by
a replicate fortified sample that yielded only 28% recovery and
effectively doubled the relative standard deviation.
Instrument variation did not contribute to the poor precision
in analyte recovery from fortified samples. As reported, examina-
tion of replicate injections of 110 pg of cabergoline under the
conditions employed for extract analysis (for the purposes of
evaluating mobile-phase strength) demonstrated a RSD of 6.1%
(n ) 5). Analyte recovery lower than 65% may have resulted from
our modifications to the published method.1 Specifically, we used
ethyl acetate as the extraction solvent because it was less likely
to form emulsions (vs 2:3 methylene chloride/isooctane) during
the liquid-liquid extraction step. Further, our modification
included complete drying of the organic solvent, prior to partition-
ing the analyte back into the aqueous phase. While this additional
step may have led to a slight reduction in cabergoline recovery,
we found it helpful because our study required that the samples
be extracted at a field animal facility and transported to the
analytical laboratory.
CONCLUSIONS
The improved sample introduction technique described here
can be achieved without specialized hardware. We employed a
guard column typically used for routine analytical separations.
Though we found some irreproducibility in peak height and width
response among manufacturing lots of columns, this could be
overcome by adjusting mobile-phase strength to produce peaks
of required quality. This sample introduction technique offered
improved selectivity and sensitivity versus flow injection and
shorter run times as compared to conventional HPLC.
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